Guidelines 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Summary document prepared by the Czech Society of Cardiology§ Richard Rokytaa,*,Martin Hutyrab,Pavel Jansac aCardiology Department, Complex Cardiovascular Center, University Hospital and Faculty of Medicine Pilsen, Charles University Prague, Czech

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology New ESC PE guidelines - still muddled in the middle? September 26, 2014. The new European PE guidelines from the ESC appear to start applying some of the evidence regarding patients without shock but with RV strain and elevated troponin/BNP. In 2014, the results of landmark clinical trials and cohort studies, particularly those published in the preceding 6 years, were included in the update of the European Society of Cardiology (ESC) guidelines on the management of PE [1]. In the 2014 ESC guidelines, which were endorsed by the European Respiratory Society (ERS), several The European Society of Cardiology (ESC) has proposed an updated risk stratification model for death in patients with acute pulmonary embolism based on clinical scores (Pulmonary Embolism Severity Index (PESI) or simplified PESI (sPESI)), right ventricle dysfunction (RVD) and elevated serum troponin (2014 ESC model). treatment and should not be interpreted as the guideline panel's order of preference for the use of these agents. Summary of Recommendations Choice of Long-Term (First 3 Months) and Extended (No Scheduled Stop Date) Anticoagulant 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) This document follows the two previous ESC Guidelines focussing on clinical management of pulmonary embolism, published in 2000 and 2008. Many recommendations have retained or reinforced their validity; however, new data has